Azora Therapeutics, Inc. (DE) (AZR) Other Accumulated Expenses (2018 - 2026)
Azora Therapeutics, Inc. (DE)'s Other Accumulated Expenses came in at $2.7 million for Q3 2026, up 425.4% from $513,169 a year earlier and up 85.0% from the prior quarter.
Azora Therapeutics, Inc. (DE) (AZR) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, Azora Therapeutics, Inc. (DE)'s Other Accumulated Expenses was $660,000, up 62.9% from FY2024.
- Other Accumulated Expenses carries a five-year compound annual growth rate of 15.4% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $405,246 in FY2024 (-3.8%), $421,365 in FY2023 (-44.7%), $761,509 in FY2022 (+46.2%) and $520,795 in FY2021 (+61.5%).
- The Q3 2026 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q4 2018.
- Year-over-year, Other Accumulated Expenses has increased for seven consecutive quarters, with growth averaging 134.8% over the last eight quarters.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2026 (growth of 425.4%), and the weakest in Q1 2024 (a decline of 82.1%).
- Business Quant data shows AZR's Other Accumulated Expenses at $1.46 million (Q2 2026), $837,509 (Q1 2026) and $660,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Azora Therapeutics, Inc. (DE) | 58.43 Mn | -2.79 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.70 Mn |
| Jun 30, 2026 | 1.46 Mn |
| Mar 31, 2026 | 837,509.00 |
| Dec 31, 2025 | 660,000.00 |
| Sep 30, 2025 | 513,169.00 |
| Jun 30, 2025 | 372,560.00 |
| Mar 31, 2025 | 588,442.00 |
| Dec 31, 2024 | 405,246.00 |
| Sep 30, 2024 | 413,557.00 |
| Jun 30, 2024 | 273,578.00 |
| Mar 31, 2024 | 196,118.00 |
| Dec 31, 2023 | 421,365.00 |
| Sep 30, 2023 | 354,107.00 |
| Jun 30, 2023 | 276,705.00 |
| Mar 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 761,509.00 |
| Sep 30, 2022 | 686,501.00 |
| Jun 30, 2022 | 498,628.00 |
| Mar 31, 2022 | 357,535.00 |
| Dec 31, 2021 | 520,795.00 |
Azora Therapeutics, Inc. (DE) Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AZR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "AZR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AZR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();